C79 Price sensitive 9 May 2025, 9:56 AM

Chrysos Enters MSA With Newmont Corporation

Chrysos Corporation Ltd

Chrysos Signs Contract with Newmont, Enters MSA

Key points

  • Chrysos enters Master Services Agreement with Newmont Corporation
  • Initial PhotonAssay unit to be installed at Newmont's Ahafo mine in Ghana
  • MSA includes optional renewable five-year term, fee per sample, and minimum monthly assay payment

Full summary

Chrysos Corporation Ltd (ASX:C79) has announced that it has entered into a Master Services Agreement (MSA) with Newmont Corporation, the world's leading gold company, for Newmont to use Chrysos' PhotonAssay technology for its gold mining projects. Chrysos and Newmont have also entered into a contract for an initial PhotonAssay unit to be installed at Newmont's Ahafo mine in Ghana, with deployment expected in the first half of the 2026 financial year. The MSA with Newmont adheres to Chrysos' general terms, including an optional renewable five-year term, a fee per sample, and a minimum monthly assay payment. Chrysos' PhotonAssay technology delivers faster, safer, more accurate and environmentally-friendly analysis of gold, silver, copper and other elements in as little as two minutes. Newmont Corporation is a leading global gold producer with a world-class portfolio of assets, prospects and talent across Africa, Australia, Latin America & Caribbean, North America and Papua New Guinea. Chrysos' Managing Director and CEO, Dirk Treasure, stated that the agreement with Newmont is a testament to the significance of PhotonAssay and the company's strategy of converting the world's biggest gold miners to its technology, a trend that is expected to accelerate as Chrysos continues to penetrate the global mining market.

Outlook

Chrysos is continuing its strategy of converting the world's biggest gold miners to its PhotonAssay technology. The company expects this trend to accelerate as it continues to penetrate the global mining market.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in